Urology Coding Alert

You Be the Coder:

Report Coaptite® Injections Regardless of Gender

Question: We have a male patient that our doctor would like to inject with Coaptite® because of stress incontinence following a radical prostatectomy. The literature states that it is for use in adult females, but the rep from Boston Scientific states he has a urologist doing them on males and getting paid. The patient has Medicare insurance coverage. Can we report this procedure to Medicare for a male patient, and if so, how?Wisconsin SubscriberAnswer: You can report this procedure for either male or female patients. You would use CPT® code 51715 (Endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck) regardless of the patient's gender. Don't miss: For the implant material you should also report HCPCS code L8606 (Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies) times the number of syringes used to the local payer who is reimbursing for [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Urology Coding Alert

View All

Which Codify by AAPC tool is right for you?

Call 844-334-2816 to speak with a Codify by AAPC specialist now.